U.S. Negotiating With Pfizer for More COVID Vaccine Doses

WEDNESDAY, Dec. 16, 2020 (Healthday News) – The Trump administration is working to free up raw materials that Pfizer requires to make tens of millions more doses of its coronavirus vaccine in the first half of 2021.
Should an agreement be struck…
Source: Topamax